Mirazid shows insignificant activity against ovine fascioliasis

References

• Abo-Madyan, A. A., Morsy, T. A. & Motawea, S. M. (2004a). Efficacy of myrrh in the treatment of schistosomiasis (haematobium and mansont) in Ezbet El-Bakly, Tamyia center, El-Fayoum governorate, Egypt. Journal of the Egyptian Society of Parasitology, 34, 423–446.
   PubMedGoogle Scholar
• Abo-Madyan, A. A., Morsy, T. A., Motawea, S. M. & Morsy, A. T. (2004b). Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia center), Al-Fayoum governorate. Journal of the Egyptian Society of Parasitology, 34, 807–818.
   PubMedGoogle Scholar
• Anderson, P. H., Berrett, S., Brush, P. J., Hebert, C. N., Parfitt, J. W. & Patterson, D. S. (1977). Biochemical indicators of liver injury in calves with experimental fascioliasis. Veterinary Record, 100, 43–45.
   PubMed Web of Science ®Google Scholar
• Anon. (2002). Problems with dietary supplements. Medical Letters, 44, 48–86.
   Google Scholar
• Apt, W., Aguilera, X., Vega, F., Miranda, C., Zulantay, I., Perez, C., Gabor, M. & Apt, P. (1995). Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. American Journal of Tropical Medicine and Hygiene, 52, 532–535.
   PubMed Web of Science ®Google Scholar
• Badria, F., Abou-Mohamed, G., El-Mowafy, A., Massoud, A. & Salama, O. (2001). Mirazid: a new schistosomidal drug. Pharmaceutical Biology, 93, 127–131.
   Google Scholar
• Barakat, R., El-Morshedy, H. & Fenwick, A. (2005). Efficacy of myrrh in the treatment of human schistosomiasis mansoni. American Journal of Tropical Medicine and Hygiene, 73, 365–367.
   PubMed Web of Science ®Google Scholar
• Benchaoui, H. A. & McKellar, Q. A. (1993). Effect of early treatment with rafoxanide on antipyrine clear-ance in sheep infected with Fasciola hepatica. Xenobiotka, 23, 439-448.
   Google Scholar
• Boray, J. C., Crowfoot, P. D., Strong, M. B., Allison, J. R., Schellenbaum, M., Von Orelli, M. & Sarasin, G. (1983). Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Record, 113, 315–317.
   PubMed Web of Science ®Google Scholar
• Botros, S., William, S., Ebeid, F., Cioli, D., Katz, N., Day, T. A. & Bennett, J. L. (2004). Lack of evidence an antischistosomal activity of myrrh in experimental animals. American Journal of Tropical Medicine and Hygiene, 71, 206-210.
   Google Scholar
• Botros, S., El-Sayed, H., El-Dusoki, H., Sabry, H., Rabie, I., El-Ghannam, M., Hassanein, M., El-Wahab, Y. A. & Engels, D. (2005). Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma-infected school children and households. American Journal of Tropical Medicine and Hygiene, 72, 119–123.
   PubMed Web of Science ®Google Scholar
• Bulgin, M. S., Anderson, B. C., Hall, R. F. & Lang, B. Z. (1984). Serum gamma glutamyl transpeptidase activity in cattle with induced fasciolosis. Research in Veterinary Science, 37, 167-171.
   Google Scholar
• Cheever, A. W. (1968). Conditions affecting the accuracy of potassium hydroxide digestion techni-ques for counting Schistosoma mansoni eggs in tissues. Bulletin of the World Health Organization, 39, 328–331.
   PubMedGoogle Scholar
• Doumas, B. T., Watson, W. R. & Biggs, H. G. (1971). Albumin standard and measurement of serum albumin with Bromocresol Green. Clinica Chimica Acta, 31, 87–96.
   PubMed Web of Science ®Google Scholar
• Ebeid, F., El-Lakkany. N., Seif El-Din, S., Sabra, A., Noseir, M. & Botros, S. (2005a). Effect of Mirazid against different developmental stages of Schistosoma mansoni worms and its safety in normal mice. Egyptian Journal of Schistosomiasis and Infectious Endemic Diseases, 27, 15–24.
   Google Scholar
• Ebeid, F. A., Mahmoud, S. S., Botros, S. S. & Badawy, A. A. (2005b). Evaluation of the antibilharzial activity of mirazid versus praziquantel against S. haemato-bium: an experimental study. Egyptian Journal of Schistosomiasis and Infectious Endemic Diseases, 27, 25–37.
   Google Scholar
• El-Mathal, E. M. & Fouad, M. A. (2005). Human fascioliasis among immigrant workers in Saudi Arabia. Journal of the Egyptian Society of Parasitology, 35, 1199-1207.
   PubMedGoogle Scholar
• El Ridi, R., Salah, M., Wagih, A., William, H., Tallima, H., El Shafie, M. H., Abdel Khalek, T., El Amir, A., Abo Ammou, F. F. & Motawi, H. (2007). Fasciola gigantica excretory—secretory products for immuno-diagnosis and prevention of sheep fasciolosis. Veterinary Parasitology, 149, 219–228.
   PubMed Web of Science ®Google Scholar
• Gajewska, A., Smaga-Kozlowska, K. & Wigniewski, M. (2005). Pathological changes of liver in infection of Fasciola hepatica. Wiadomoki Parazytologiczne, 51, 115–123.
   PubMedGoogle Scholar
• Galtier, P., Larrieu, G., Tufenkji, A. E. & Franc, M. (1986). Incidence of experimental fasciolosis on the activity of drug-metabolizing enzymes in lamb liver. Drug Metabolism and Disposition, 14, 137-141.
   PubMed Web of Science ®Google Scholar
• Greene, D. A. (1993). Gold, frankincense, myrrh and medicine. North Carolina Medical Journal, 54, 620–622.
   PubMedGoogle Scholar
• Guirgis, F. R. & Mahmoud, S. S. (2003). On the efficacy of a new antischistosomal drug (Mirazid) against Schistosoma haematobium and S. mansoni: an in vivo study. Journal of the Egyptian and German Societies of Zoology, 42, 89–98.
   Google Scholar
• Haridy, F. M., El-Sherbiny, G. T. & Morsy, T. A. (2006). Some parasitic flukes infecting farm animals in Al-Santa center, Gharbia governorate, Egypt. Journal of the Egyptian Society of Parasitology, 36, 259-264.
   Google Scholar
• Hassan, M. M., Abbaza, B. E., El-Karamany, I., Dvab, A. K., El-Sharkawy, E. M., Ismail, F. & Asal, K. H. (2004). Detection of anti-Fasciola isotypes among patients with fascioliasis before and after treatment with Mirazid. Journal of the Egyptian Society of Parasitology, 34, 857-864.
   Google Scholar
• Hien, T. T., Truong, N. T., Minh, N. H., Dat, H. D., Dung, N. T., Hue, N. T., Dung, T. K., Tuan, P. Q., Campbell, J. I., Farrar, J. J. & Day, J. N. (2008). A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Viemam. American Journal of Tropical Medicine and Hygiene, 78, 388–392.
   PubMed Web of Science ®Google Scholar
• Katz, N. Z., Coelho, P. M. Z. & Pellegrino, J. (1970). Evaluation of Kato quantitative method through the recovery of Schistosoma mansoni eggs added to human faeces. Parasitology, 56, 1032–1033.
   Web of Science ®Google Scholar
• Keiser, J. & Morson, G. (2008). Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. Experimental Parasitology, 118, 228–237.
   PubMed Web of Science ®Google Scholar
• Keiser, J. & Utzinger, J. (2005). Emerging foodbome trematodiasis. Emerging Infectious Diseases, 11, 1507–1514 .
   PubMed Web of Science ®Google Scholar
• Keiser, J., Utzinger, J., Vennerstrom, J. L., Dong, Y., Brennan, G. & Fairweather, I. (2007). Activity of artemether and 0Z78 against triclabendazole-resis-tant Fasciola hepatica. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 1219-1222.
   Google Scholar
• Kind, P. & King, E. J. (1954). Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. Journal of Clinical Pathology, 7, 322.
   PubMed Web of Science ®Google Scholar
• Maher, K., El Ridi, R., Nour Elhoda, A., El-Ghannam, M., Shaheen, H., Shaker, Z. & Hassanein, H. I. (1999). Parasite-specific antibody profile in human fascioliasis: application for immunodiagnosis of infection. American Journal of Tropical Medicine and Hygiene, 61, 738-742
   Google Scholar
• Martínez-Moreno, A., Martinez-Moreno, F. J., Acosta, I., Gutierrez, P. N., Becerra, C. & Hernández, S. (1997). Humoral and cellular immune responses to experimental Fasciola hepatica infections in goats. Parasitology Research, 83, 680–686.
   PubMed Web of Science ®Google Scholar
• Martínez-Moreno, A., Jimenez-Luque, V., Moreno, T., Redondo, E. S. H., de las Mulas, J. M. & Perez, J. (1999). Liver pathology and immune response in experimental Fasciola hepatica infections of goats. Veterinary Parasitology, 82, 19-33.
   Google Scholar
• Mas-Coma, S. (2005). Epidemiology of fascioliasis in human endemic areas. Journal of Helminthology, 79, 207–216.
   PubMed Web of Science ®Google Scholar
• Mas-Coma, S., Bargues, M. D. & Esteban, J. G. (1999). Human fasciolosis. In Fasciolosis, ed. Dalton, J. P. pp. 411-434. Wallingford, U.K.: CABI Publishing.
   Google Scholar
• Massoud, A., El-Sisi, S., Salama, O. & Massoud, A. (2001). Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). American Journal of Tropical Medicine and Hygiene, 65, 96–99.
   PubMed Web of Science ®Google Scholar
• McConville, M., Brennan, G. P., Flanagan, A., Edgar, H. W. J., McCoy, M., Castillo, R., Hernandez-Campos, A. & Fairweather, I. (2008). Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experi-mental fasciolicide, compound alpha. Veterinary Parasitology, 153, 52–64.
   PubMed Web of Science ®Google Scholar
• McManus, D. P. & Dalton, J. P. (2006). Vaccines against the zoonotic trematodes Schistosoma japoni-cum, Fasciola hepatica and Fasciola gigantica. Parasitology, 133 (Suppl.), S43-S61.
   Google Scholar
• Michie, C. A. & Cooper, E. (1991). Frankincense and myrrh as remedies in children. Journal of the Royal Society of Medicine, 84, 602–605.
   PubMed Web of Science ®Google Scholar
• Moran, J., Addy, M. & Roberts, S. (1992). A comparison of natural product, triclosan and chlor-hexidine mouthrinses on 4-day plaque regrowth. Journal of Clinical Periodontology, 19, 578–582.
   PubMed Web of Science ®Google Scholar
• Morsy, T. A., Salem, H. S., Handy, F. M., Riffat, M. M., Abo-Zenadah, N. Y. & El-Kadi, A. M. (2005). Farm animals' fascioliasis in Ezbet El-Bakly (Tamyia center), Al-Fayoum governorate. Journal of the Egyptian Society of Parasitology, 35, 825-832.
   PubMedGoogle Scholar
• Persijn, J. & van der Slik, W. (1976). A new method for the determination of gamma glutamyl transferase in serum. Journal of Clinical Chemistry and Clinical Biochemistry, 14, 421-427.
   PubMedGoogle Scholar
• Phiri, I. K., Phiri, A. M. & Harrison, L. J. S. (2007). The serum glucose and fl-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection. Veterinary Parasitology, 143, 287-293.
   Google Scholar
• Raadsma, H. W., Kingsford, N. M., Suharyanta Spithill, T. W. & Piedrafita, D. (2007). Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep: I. Comparative immunological and plasma biochemical changes during early infection. Veterinary Parasitology, 143, 275-286.
   Google Scholar
• Rapic, D., Dzakula, N., Sakar, D. & Richards, R. J. (1988). Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle. Veterinary Record, 122, 59–62.
   PubMed Web of Science ®Google Scholar
• Reitman, S. & Frankel, S. (1957). A colourimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28, 56-63.
   Google Scholar
• Richards, R. J., Bowens, F. L., Essenwein, F., Steiger, R. F. & Biischer, G. (1990). The efficacy of triclabendazole and other anthelmintics against Fasciola hepatica in controlled studies in cattle. Veterinary Record, 126, 213-216.
   Google Scholar
• Sandemen, R. M. & Howell, M. J. (1981). Response of sheep to challenge infection with Fasciola hepatica. Research in Veterinary Science, 30, 294–297.
   PubMed Web of Science ®Google Scholar
• Sheir, Z., Naser, A. A., Massoud, A., Salama, O., Badra, G. A., El-Shennawy, H., Hassan, N. & Hammad, S. M. (2001). A safe, effective, herbal anti-schistosomal therapy derived from myrrh. American Journal of Tropical Medicine and Hygiene, 65, 700–704.
   PubMed Web of Science ®Google Scholar
• Smeal, M. G. & Hall, C. A. (1983). The activity of triclabendazole against immature and adult Fasciola hepatica infections in sheep. Australian Veterinary Journal, 60, 329–331.
   PubMed Web of Science ®Google Scholar
• Soliman, O. E., El-Arman, M., Abdul-Samie, E. R., El-Nemr, H. I. & Massoud, A. (2004). Evaluation of myrrh (Mirazid) therapy in fascioliasis and intestinal schistosomiasis in children: immunological and parasitological study. Journal of the Egyptian Society of Parasitology, 34, 941–966.
   PubMedGoogle Scholar
• Suhardono, Roberts, J. A. & Copeman, D. B. (2006). Optimization of the procedure for counting the eggs of Fasciola gigantica in bovine faeces. Tropical Animal Health and Production, 38, 383-387.
   PubMed Web of Science ®Google Scholar
• Thienpont, D., Rochette, F. & Vanparijs, O. F. J. (1979). Diagnosing Helminthiasis Through Coprological Examination. Beerse, Belgium: Janssen Research Foundation.
   Google Scholar
• Turner, K., Armour, J. & Richards, R. J. (1984). Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep. Veterinary Record, 114, 41-42.
   Google Scholar
• Weichselbaum, P. E. (1946). An accurate and rapid method for determination of protein in small amounts of blood serum and plasma. American Journal of Tropical and Clinical Pathology, 16, 40.
   PubMed Web of Science ®Google Scholar
• Weigl, E., Bach, H. & Krieg, D (1975). Serum bilirubin in an obvious healthy population. Medizinische 70, 664-669.
   Google Scholar
• Wolff, K., Eckert, J., Schneiter, G. & Lutz, H. (1983). Efficacy of triclabendazole against Fasciola hepatica in sheep and goats. Veterinary Parasitology, 13, 145–150.
   PubMed Web of Science ®Google Scholar
• Wood, I. B., Amaral, N. K., Bairden, K., Duncan, J. L., Kassi, T., Malone, J. B., Jr, Pankavich, J. A., Reinecke, R. K., Slocombe, O., Taylor, S. M. & Vercruysse, J. (1995). World Association for the Advancement of Veterinary Parasitology (WAAVP) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine). Veterinary Parasitology, 58, 181–213.
   PubMed Web of Science ®Google Scholar